Alkem Labs Q2 Results: Net profit rises 11% to Rs 689 crore
Alkem Laboratories on Wednesday posted a 11% year-on-year (y-o-y) jump in net profit to Rs 689 crore in Q2FY25 led by growth in domestic formulation sales.
The company reported Rs 620.5 crore in the corresponding quarter of the previous year.
Revenue from operations declined 0.7% y-o-y to Rs 3414.7 crore in Q2FY25.
Earnings before interest, tax, depreciation, and amortization (EBITDA) increased by 0.8% y-o-y to Rs 753 crore, resulting in an EBITDA margin of 22% in Q2FY22 compared to 21.7% in Q2FY24.
R&D expenses for the quarter were Rs 146.5 crore or 4.3% of total revenue from operations.
Stock Trading
Ichimoku Trading Unlocked: Expert Analysis and Strategy
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Advanced Strategies in Stock Market Mastery
By — CA Raj K Agrawal, Chartered Accountant
Stock Trading
RSI Made Easy: RSI Trading Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Stock Valuation Made Easy
By — Rounak Gouti, Investment commentary writer, Experience in equity research
Stock Trading
Technical Analysis Demystified: A Complete Guide to Trading
By — Kunal Patel, Options Trader, Instructor
Stock Trading
Heikin Ashi Trading Tactics: Master the Art of Trading
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
By — Saketh R, Founder- QuickAlpha, Full Time Options Trader
Stock Trading
Complete Guide to Stock Market Trading: From Basics to Advanced
By —
